Gene · 338399
Papers2,833
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,833
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Age-dependent changes on fractalkine forms and their contribution to neurodegenerative diseases. | Front Mol Neurosci | 2023 | 37818457 | PubTator, text mining | PubMed |
| Factors associated with early discontinuation of anamorelin in patients with cancer-associated cachexia. | Support Care Cancer | 2023 | 37815652 | PubTator, text mining | PubMed |
| Best practices for perturbation MPRA-a computational evaluation framework of sequence design strategies. | bioRxiv | 2023 | 37808807 | PubTator, text mining | PubMed |
| URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers. | Nat Commun | 2023 | 37805657 | PubTator, text mining | PubMed |
| Long non-coding RNAs: The hidden players in diabetes mellitus-related complications. | Diabetes Metab Syndr | 2023 | 37797393 | PubTator, text mining | PubMed |
| Compartmentalization of androgen receptors at endogenous genes in living cells. | Nucleic Acids Res | 2023 | 37791849 | PubTator, text mining | PubMed |
| Identification of methylation-regulated genes modulating microglial phagocytosis in hyperhomocysteinemia-exacerbated Alzheimer's disease. | Alzheimers Res Ther | 2023 | 37789414 | PubTator, text mining | PubMed |
| 15-month post-COVID syndrome in outpatients: Attributes, risk factors, outcomes, and vaccination status - longitudinal, observational, case-control study. | Front Immunol | 2023 | 37781408 | PubTator, text mining | PubMed |
| Will metformin use lead to a decreased risk of thyroid cancer? A systematic review and meta-analyses. | Eur J Med Res | 2023 | 37773165 | PubTator, text mining | PubMed |
| Ginsenoside F1-Mediated Telomere Preservation Delays Cellular Senescence. | Int J Mol Sci | 2023 | 37762556 | PubTator, text mining | PubMed |
| Amphibian-Derived Natural Anticancer Peptides and Proteins: Mechanism of Action, Application Strategies, and Prospects. | Int J Mol Sci | 2023 | 37762285 | PubTator, text mining | PubMed |
| Current Advances in Mitochondrial Targeted Interventions in Alzheimer's Disease. | Biomedicines | 2023 | 37760774 | PubTator, text mining | PubMed |
| Uncovering the Early Events Associated with Oligomeric Aβ-Induced Src Activation. | Antioxidants (Basel) | 2023 | 37760073 | PubTator, text mining | PubMed |
| Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy. | Biomolecules | 2023 | 37759788 | PubTator, text mining | PubMed |
| Influence of Metabolic, Transporter, and Pathogenic Genes on Pharmacogenetics and DNA Methylation in Neurological Disorders. | Biology (Basel) | 2023 | 37759556 | PubTator, text mining | PubMed |
| Identification and verification of genes associated with hypoxia microenvironment in Alzheimer's disease. | Sci Rep | 2023 | 37759083 | PubTator, text mining | PubMed |
| A curated census of pathogenic and likely pathogenic UTR variants and evaluation of deep learning models for variant effect prediction. | Front Mol Biosci | 2023 | 37745687 | PubTator, text mining | PubMed |
| The role of microRNAs in neurobiology and pathophysiology of the hippocampus. | Front Mol Neurosci | 2023 | 37727513 | PubTator, text mining | PubMed |
| International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND). | J Neurodev Disord | 2023 | 37710171 | PubTator, text mining | PubMed |
| MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer's disease. | Science | 2023 | 37708272 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338399/papers?page=13